ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis
- PMID: 10630188
- DOI: 10.1006/exnr.1999.7190
ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis
Abstract
We employed a mouse model of ALS, in which overexpression of a familial ALS-linked Cu/Zn-SOD mutation leads to progressive MN loss and a clinical phenotype remarkably similar to that of human ALS patients, to directly test the excitotoxicity hypothesis of ALS. Under basal culture conditions, MNs in mixed spinal cord cultures from the Cu/Zn-SOD mutant mice exhibited enhanced oxyradical production, lipid peroxidation, increased intracellular calcium levels, decreased intramitochondrial calcium levels, and mitochondrial dysfunction. MNs from the Cu/Zn-SOD mutant mice exhibited greatly increased vulnerability to glutamate toxicity mediated by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptors. The increased vulnerability of MNs from Cu/Zn-SOD mutant mice to glutamate toxicity was associated with enhanced oxyradical production, sustained elevations of intracellular calcium levels, and mitochondrial dysfunction. Pretreatment of cultures with vitamin E, nitric oxide-suppressing agents, peroxynitrite scavengers, and estrogen protected MNs from Cu/Zn-SOD mutant mice against excitotoxicity. Excitotoxin-induced degeneration of spinal cord MNs in adult mice was more extensive in Cu/Zn-SOD mutant mice than in wild-type mice. The mitochondrial dysfunction associated with Cu/Zn-SOD mutations may play an important role in disturbing calcium homeostasis and increasing oxyradical production, thereby increasing the vulnerability of MNs to excitotoxicity.
Similar articles
-
N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx.J Neurosci Res. 2001 Mar 1;63(5):377-87. doi: 10.1002/1097-4547(20010301)63:5<377::AID-JNR1032>3.0.CO;2-#. J Neurosci Res. 2001. PMID: 11223912
-
Excitotoxic motoneuron degeneration induced by glutamate receptor agonists and mitochondrial toxins in organotypic cultures of chick embryo spinal cord.J Comp Neurol. 2009 Oct 1;516(4):277-90. doi: 10.1002/cne.22118. J Comp Neurol. 2009. PMID: 19634179
-
ALS-linked Cu/Zn-SOD mutation impairs cerebral synaptic glucose and glutamate transport and exacerbates ischemic brain injury.J Cereb Blood Flow Metab. 2000 Mar;20(3):463-8. doi: 10.1097/00004647-200003000-00004. J Cereb Blood Flow Metab. 2000. PMID: 10724110
-
Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.Prog Neurobiol. 2008 May;85(1):94-134. doi: 10.1016/j.pneurobio.2008.01.001. Epub 2008 Jan 16. Prog Neurobiol. 2008. PMID: 18282652 Review.
-
Excitotoxicity and amyotrophic lateral sclerosis.Neurodegener Dis. 2005;2(3-4):147-59. doi: 10.1159/000089620. Neurodegener Dis. 2005. PMID: 16909020 Review.
Cited by
-
NSC-34 Motor Neuron-Like Cells Are Unsuitable as Experimental Model for Glutamate-Mediated Excitotoxicity.Front Cell Neurosci. 2016 May 9;10:118. doi: 10.3389/fncel.2016.00118. eCollection 2016. Front Cell Neurosci. 2016. PMID: 27242431 Free PMC article.
-
Selective vulnerability of motoneuron and perturbed mitochondrial calcium homeostasis in amyotrophic lateral sclerosis: implications for motoneurons specific calcium dysregulation.Mol Cell Ther. 2014 Aug 14;2:26. doi: 10.1186/2052-8426-2-26. eCollection 2014. Mol Cell Ther. 2014. PMID: 26056593 Free PMC article. Review.
-
Multi-Study Proteomic and Bioinformatic Identification of Molecular Overlap between Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA).Brain Sci. 2018 Dec 4;8(12):212. doi: 10.3390/brainsci8120212. Brain Sci. 2018. PMID: 30518112 Free PMC article.
-
Stimulation-induced mitochondrial [Ca2+] elevations in mouse motor terminals: comparison of wild-type with SOD1-G93A.J Physiol. 2003 Jun 15;549(Pt 3):719-28. doi: 10.1113/jphysiol.2003.041905. Epub 2003 Apr 25. J Physiol. 2003. PMID: 12717010 Free PMC article.
-
Mitochondrial medicine for neurodegenerative diseases.Int J Biochem Cell Biol. 2010 May;42(5):560-72. doi: 10.1016/j.biocel.2010.01.004. Epub 2010 Jan 11. Int J Biochem Cell Biol. 2010. PMID: 20067840 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous